glp 1 success IBX members face GLP-1 drug costs after insurance change GLP-1s and the Unintended Consequences

Sort of like looking for the shape of a keyhole into which a given key would fit

The typical maintenance doses for GLP-1 receptor agonists are: liraglutide 1.8 mg daily, semaglutide 1.0 mg weekly (injectable) or 14 mg daily (oral), and du...

Tirzepatide is the first dual long-acting glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist indicated for the treatment of type 2 diabetes in adults, for reducing excess body weight and maintaining ...

Adding Dexcom G7 to your GLP-1 therapy leads to lower A1C than GLP-1 alone and helps you realize your goals faster

What the 2025 Gastroenterology Metaanalysis Found The systematic review and metaanalysis (DOI: 10.1053/j.gastro.2025.06.003) evaluated safety outcomes across randomized trials and realworld studies of GLP1 RAs